Covid-19

CORONAVIRUS GLOBAL UPDATE

Hong Kong test plan in flux; South Africa registers 1,436 new cases

Members of the public wait in line outside a vaccination facility administering the Moderna Covid-19 vaccine at a shopping mall in Taipei, Taiwan, on 17 January 2022. (Photo: I-Hwa Cheng / Bloomberg via Getty Images)
By Bloomberg
08 Mar 2022 0

South Africa registered 1,436 new Covid-19 cases, bringing the cumulative total to 3,686,556. A further 16 Covid-19-related deaths were reported, taking total official deaths to 99,625. A total of 32,225,496 vaccines have been administered.

Hong Kong’s plan to test the whole city three times in March is now in flux as pressure grows on the government to focus resources instead on addressing a Covid death rate that has surged to the highest in the world.

A Ming Pao report said Hong Kong is considering prioritising reducing Covid-19 deaths over the compulsory citywide test. A later report by the South China Morning Post said the city could postpone testing to April. A health official said at a regular briefing on Tuesday that details are still under discussion.

On Tuesday, the city announced 28,475 new Covid cases that were positive in a PCR test. Separately, health officials said a new website allowing residents to self-report positive rapid-antigen tests received more than 17,000 submissions, with about 14,700 considered valid – though the number covers results across March 6 and March 7 and weren’t included in the daily total.

Authorities reported 160 deaths, including a four-year-old girl announced Monday, with most fatalities elderly and unvaccinated. There are 74 patients in a critical condition in hospital and 105 in a serious condition. New modelling by researchers at the University of Hong Kong estimated cumulative deaths by May 1 will be 5,008 if there are no changes to transmission dynamics and interventions.

Hong Kong’s hair salons will be allowed to reopen on Thursday, provided they have a vaccine pass. Most physical-distancing curbs will be extended to March 23, including banning dine-in services at restaurants after 6pm and limiting multi-household gatherings on private premises.

Key developments 

  • Virus Tracker: Cases exceed 447 million; deaths top 6 million
  • Vaccine Tracker: More than 10.8 billion doses administered
  • What we know about Hong Kong’s likely Covid lockdown: Quicktake
  • Parents have new headache as masks in school become option
  • Exiting Covid-zero risks inundating China’s unprepared hospitals
  • Vaccine religious exemption fight turned away by Supreme Court
  • Coronavirus Daily: Vaccines held up for kids amid Omicron

China cases top 500 for second day 

China saw its daily domestic Covid-19 infections topping 500 for a second day as Omicron caused multiple clusters across the country. The resurgence is the worst China has seen since bringing its initial outbreak centred around Wuhan under control in early 2020.

A total of 330 infections reported on Tuesday are asymptomatic, as Omicron quickly spreads among students in the eastern city of Qingdao and workers in the southern manufacturing hub of Dongguan. 

The highly infectious variant also spawned a scattered spread in Shanghai, which has so far sought to contain the flare-up through targeted response and to refrain from mass testing, travel bans and lockdowns frequently used in other parts of China. Beijing also reported new infections on Tuesday amid the annual parliamentary meeting attended by lawmakers from across the country.

Zhang Wenhong, a renowned infectious disease doctor who advises the Shanghai municipal government on Covid control and treatment, said on his Twitter-like Weibo account Monday that implementing a Covid-zero strategy should not come at the expense of sacrificing normal life.

Shares of Chinese drug maker Meheco surge on Pfizer partner talk  

Shares of state-owned China Meheco shot up more than 50% in the past week amid speculation that the Beijing-based drug maker will be the local partner for Pfizer’s Covid-19 treatment pill.

China conditionally approved Pfizer’s Paxlovid last month, making it the first foreign pharmaceutical product that Beijing has endorsed for Covid-19. China Meheco is the only drug company that’s overseen by the central government, leading investors to bet that it will be the local distributor instead of a private company.

Australia’s business sentiment rebounds as Omicron recedes 

Australian business sentiment strengthened in February as an outbreak of the Omicron variant of coronavirus dissipated, easing supply-chain disruptions and reviving demand. 

Business confidence jumped to 13 points from a revised four in January, recording gains across all industries, a National Australia Bank survey showed on Tuesday. Business conditions – measuring hiring, sales and profits –  climbed to nine points from a revised two to be back above its long-run average. The poll was largely concluded before Russia invaded Ukraine, NAB said.

Separately, according to the CommBank HSI Index report released in Sydney, Australia’s household spending intentions rose 1.8% to 107.3 from a month earlier in February.

Business lobby tells Japan’s government to declare Covid endemic 

Japan Business Federation, or Keidanren, the country’s largest business lobbying group, has asked that the government plan the nation’s exit strategy from the pandemic immediately, according to a policy paper it released on Monday.

The government should declare Covid is endemic as soon as possible and move on, it said.

Moderna readying for next pandemic 

Moderna plans to start human trials for vaccines against 15 threatening viruses and other pathogens by 2025, part of a strategy to develop shots that could be made quickly in response to a future pandemic.

The effort will include prototype vaccines against the virus that causes Middle East respiratory syndrome, a cousin of Covid-19; the Ebola and Marburg viruses; a tick-borne virus that causes Crimean-Congo haemorrhagic fever; and mosquito-borne viruses such as chikungu.  

Hong Kong may drop mass testing as priority 

Hong Kong’s government is considering a “drastic shift” in its efforts to contain a Covid-19 outbreak by focusing on cutting the number of deaths as a top priority instead of compulsory mass testing, Ming Pao reports, citing an unidentified person in the government.

Lowering deaths, lessening severe cases and cutting infections have been suggested by visiting Chinese top Covid-19 expert Liang Wannian as priorities, the report said.

According to the Hong Kong Economic Times, about 260,000 people were queuing online to register with the government’s new platform for positive rapid antigen test results within the first four hours of its launch.

Hong Kong urges brokers to update continuity plan 

Hong Kong’s Securities and Futures Commission reminded securities firms to review and update their business continuity plan as the city faces the most severe outbreak since the pandemic began.

The regulator urged brokerages to start preparing now and considering the number of actions that may need to be taken ahead of a proposed citywide mandatory Covid-19 testing to ensure their operations will not be affected, according to a circular.

Businesses should critically review the impact of sudden disruptive events, including the possibility of staff shortages or reduced service offerings by essential vendors and service providers, as a result of positive cases identified during the mass testing.

Hong Kong drafts plans to get private hospitals to ease the burden

The Hong Kong government is drawing up plans to require private hospitals to provide beds and designated clinics for Covid-19 patients in an arrangement similar to asking hotels to offer quarantine facilities, South China Morning Post has reported, citing an unidentified person.

Officials have been meeting the heads of private hospitals to press for more support to ease the burden on a public healthcare system pushed to the brink attempting by the latest outbreak

Moderna erases $52bn in annual value as rout deepens 

Moderna’s shares have dropped by 50% this year as investors pulled back from Covid-19 healthcare stocks and staged a broader rotation out of growth names.

The biotech firm fell by 7.3% on Monday amid a broader market selloff and has erased $52-billion in value this year. Investors were concerned over the future revenue of Covid-19 vaccines and increasing competition in the space. The stock has fallen by about 74% from its record closing high of $484.47 set in August 2021. 

Brazil, Mexico, Argentina report latest stats 

Brazil reported a total of 29,069,469 Covid-19 cases, with 20,456 confirmed in the last 24 hours, according to Health Ministry data. The country’s coronavirus death toll rose by 198 in the last 24 hours to 652,341.

Mexico reported 42 new Covid-19 deaths on Monday, bringing the total to 319,901, according to Health Ministry data. Mexico has administered 183,629,633 doses of vaccine against coronavirus, with 85,344,341 people receiving at least one dose and 79,127,835 people fully vaccinated

Argentina reported 6,286 new Covid-19 cases on Monday, bringing the total to 8,942,888, according to Health Ministry data. Deaths increased 75 to 126,842, while 8,744,742 people have recovered.

US cases at 79.3 million

Coronavirus cases in the US were little changed as compared to the same time on Monday at 79.3 million, as of 3.50pm New York time, according to data collected by Johns Hopkins University and Bloomberg News.

The national increase in cases matched the average daily increase of less than 0.1% over the past week. California had the largest number of confirmed cases at 9.01 million, a 0.1% increase from the same time the previous day

Florida Surgeon-General Joseph Ladapo said the state would recommend against vaccinating healthy children for Covid-19, a position that contradicts guidance from the US Centers for Disease Control and Prevention.

Sanofi to invest €935-million to develop mRNA vaccines in France 

French drugmaker Sanofi plans to invest €935-million over the next few years to develop messenger RNA vaccines in France, a push into the technology behind some of the most effective Covid-19 shots.

Sanofi plans to spend the money through 2026 as part of a €2-billion  global investment programme announced last July to accelerate its mRNA strategy, according to a statement on Monday.

Sanofi is rushing to catch up with rivals like Moderna and the BioNTech-Pfizer alliance that generated tens of billions of dollars in revenue and saved lives by rapidly developing mRNA Covid vaccines.

US workers who went back to the office up to 38% 

Workers who went to the office in 10 of the largest US business districts rose to 38% of pre-Covid-19 levels in the week ended March 2, according to data from Kastle Systems.

Employees who went to the office increased by 1.2 percentage points from 36.8% the previous week

Italy reports 33,942 fewer new cases 

In the week ending March 6, Italy reported 33,942 fewer new Covid-19 cases and 244 fewer deaths than the week before, according to data released by the Italian government.

Total cases have decreased to one million, a decrease of 105,937 from a week ago but a rise of 550,529 from a year earlier.

Indonesia scraps Covid test requirement for domestic travellers 

Indonesia won’t require domestic travellers to show a negative test result for Covid-19 if they have been fully vaccinated, as the country continues to ease virus curbs.

The decision will be set out in a ministerial rule to be issued soon, said Coordinating Minister for Investment and Maritime Affairs Luhut Panjaitan, who oversees the pandemic response for Java and Bali. The government could lift all quarantine requirements for international visitors on April 1 or earlier if an ongoing trial in Bali proves successful, he added. DM/MC

– With assistance from Swati Pandey, Peter Vercoe, Dominic Lau, Dong Lyu and Rosalie E’silva.

Gallery

"Information pertaining to Covid-19, vaccines, how to control the spread of the virus and potential treatments is ever-changing. Under the South African Disaster Management Act Regulation 11(5)(c) it is prohibited to publish information through any medium with the intention to deceive people on government measures to address COVID-19. We are therefore disabling the comment section on this article in order to protect both the commenting member and ourselves from potential liability. Should you have additional information that you think we should know, please email [email protected]"

Please peer review 3 community comments before your comment can be posted